☆ 4.7 Article

Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Volume 52, Issue 4, Pages 543-546

Publisher

OXFORD UNIV PRESS

DOI: 10.1093/jac/dkg405

Keywords

ribavirin; viramidine; hepatitis C virus; HCV; prodrugs

Categories

Infectious Diseases Microbiology Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.